# wombat urls ß PLOS Biology: Partial Inhibition of Adipose Tissue Lipolysis Improves Glucose Metabolism and Insulin Sensitivity Without Alteration of Fat Mass
Advertisement
Research Article

Partial Inhibition of Adipose Tissue Lipolysis Improves Glucose Metabolism and Insulin Sensitivity Without Alteration of Fat Mass

  • Amandine Girousse,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Geneviève Tavernier,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Carine Valle,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Cedric Moro,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Niklas Mejhert,

    Affiliation: Department of Medicine, Karolinska Institute at Karolinska Hospital, Huddinge, Stockholm, Sweden

    X
  • Anne-Laure Dinel,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Marianne Houssier,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Balbine Roussel,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Aurèle Besse-Patin,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Marion Combes,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Lucile Mir,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Laurent Monbrun,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Véronic Bézaire,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Bénédicte Prunet-Marcassus,

    Affiliation: Physiogenex, Prologue Biotech, Labège-Innopole, France

    X
  • Aurélie Waget,

    Affiliations: University of Toulouse, UMR1048, Paul Sabatier University, France, INSERM, UMR1048,Team 2, I2MC, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France

    X
  • Isabelle Vila,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Sylvie Caspar-Bauguil,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France, Toulouse University Hospitals, Laboratory of Clinical Biochemistry, Toulouse, France

    X
  • Katie Louche,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Marie-Adeline Marques,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Aline Mairal,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Marie-Laure Renoud,

    Affiliations: University of Toulouse, UMR1048, Paul Sabatier University, France, INSERM, UMR1048, Team 1, I2MC, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France

    X
  • Jean Galitzky,

    Affiliations: University of Toulouse, UMR1048, Paul Sabatier University, France, INSERM, UMR1048, Team 1, I2MC, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France

    X
  • Cecilia Holm,

    Affiliation: Department of Experimental Medical Science, Lund University, Lund, Sweden

    X
  • Etienne Mouisel,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Claire Thalamas,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France, Toulouse University Hospitals, INSERM, Clinical Investigation Center, Toulouse, France

    X
  • Nathalie Viguerie,

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France

    X
  • Thierry Sulpice,

    Affiliation: Physiogenex, Prologue Biotech, Labège-Innopole, France

    X
  • Rémy Burcelin,

    Affiliations: University of Toulouse, UMR1048, Paul Sabatier University, France, INSERM, UMR1048,Team 2, I2MC, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France

    X
  • Peter Arner,

    Affiliation: Department of Medicine, Karolinska Institute at Karolinska Hospital, Huddinge, Stockholm, Sweden

    X
  • Dominique Langin mail

    dominique.langin@inserm.fr

    Affiliations: INSERM, UMR1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France, University of Toulouse, UMR1048, Paul Sabatier University, France, Toulouse University Hospitals, Laboratory of Clinical Biochemistry, Toulouse, France

    X
  • Published: February 19, 2013
  • DOI: 10.1371/journal.pbio.1001485

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.